Back to Search Start Over

Ileal Predominance in Crohn’s Disease Is Associated With Increased Intestinal Surgery and Biological Therapy Use, With Lower Treatment Persistence.

Authors :
Giordano, Antonio
Pérez-Martínez, Isabel
Gisbert, Javier P.
Ricart, Elena
Dolores Martín-Arranz, María
Mesonero, Francisco
De Castro Parga, María Luisa
Rivero, Montserrat
Iglesias, Eva
Fernández-Prada, Samuel
Calafat, Margalida
Arroyo Villarino, María Teresa
de Jorge Turrión, Miguel Ángel
Hernandez-Camba, Alejandro
Vicente Lidón, Raquel
Carpio, Daniel
Brunet, Eduard
Rodríguez Moranta, Francisco
Arias García, Lara
Tosca Cuquerella, Joan
Source :
American Journal of Gastroenterology (Lippincott Williams & Wilkins). Jan2025, Vol. 120 Issue 1, p194-203. 10p.
Publication Year :
2025

Abstract

INTRODUCTION: Crohn’s disease (CD) varies by location, potentially affecting therapy efficacy and surgery risk, although research on this topic is conflicting. This study aims to investigate the independent association between CD location and therapeutic patterns. METHODS: We analyzed patients with CD diagnosed from January 2005 to May 2023 registered in the nationwide ENEIDA registry. A univariate Cox regression analysis assessed the association of disease location with biologic use and persistence (with treatment discontinuation as a failure event), as well as the use of intestinal resections. A multivariate model was constructed to evaluate the independent association of disease location with therapeutic patterns, controlling for potential confounders such as sex, age at inclusion and diagnosis, disease duration and behavior, previous surgery or biological therapy, extraintestinal manifestations, and perianal disease. RESULTS: The study included 17,292 patients with a median follow-up period of 6 years (interquartile range 2–10 years). Ileocolonic location was associated with a higher biologic use than colonic location (hazard ratio [HR] 1.30, 95% confidence interval [CI] 1.22–1.38) and ileal disease (HR 1.21, 95% CI 1.16–1.27), independently predicting biologic use (P < 0.001). Ileal location was associated with a lower biologic persistence than ileocolonic location (HR 1.14, 95% CI 1.07–1.21) and colonic disease (HR 1.10, 95% CI 1.01–1.20), independently predicting biologic persistence (P 5 0.019). Ileal disease was associated with a higherlikelihood of intestinal resections than colonic (HR 2.82, 95% CI 2.45–3.25) and ileocolonic location (HR 1.13, 95% CI 1.05–1.22), independently predicting the use of surgery (P < 0.001). DISCUSSION: CD location with ileal predominance is associated with a distinct therapeutic pattern, including higher biologic use, lower treatment persistence, and increased rates of intestinal resections. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
00029270
Volume :
120
Issue :
1
Database :
Academic Search Index
Journal :
American Journal of Gastroenterology (Lippincott Williams & Wilkins)
Publication Type :
Academic Journal
Accession number :
182353455
Full Text :
https://doi.org/10.14309/ajg.0000000000003207